MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05439nam a22003615a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
12537381 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20180118130528.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
140508s2012 nyua frb 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1259009327 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781259009327 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EG-ScBUE |
| Language of cataloging |
eng |
| Transcribing agency |
EG-ScBUE |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1 |
| Item number |
BAS |
| Edition number |
22 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Basic & clinical pharmacology / |
| Statement of responsibility, etc |
edited by Bertram G. Katzung, Susan B. Masters, Anthony J. Trevor. |
| 246 3# - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Basic and clinical pharmacology |
| 246 30 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Pharmacology |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
12th ed., International ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York : |
| Name of publisher, distributor, etc |
McGraw-Hill Meadical, |
| Date of publication, distribution, etc |
2012. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 1229 p. : |
| Other physical details |
ill. (col.) ; |
| Dimensions |
28 cm. |
| 490 0# - Series Statement |
|---|
| Series statement |
Lange medical book |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Index : p. 1171-1229. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Previous editions copyright � 2010, 2009, 2007, 2004, 2001 by McGraw-Hill Companies, Inc.; copyright � 1998, 1995, 1992, 1989, 1987 by Appleton & Lange; copyright � 1984, 1982 by Lange Medical Publications. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section I. Basic principles -- Chapter 1. Introduction -- Chapter 2. Drug receptors & pharmacodynamics -- Chapter 3. Pharmacokinetics & pharmacodynamics: rational dosing & the time course of drug action -- Chapter 4. Drug biotransformation -- Chapter 5. Development & regulation of drugs -- Section II. Autonomic drugs -- Chapter 6. Introduction to autonomic pharmacology -- Chapter 7. Cholinoceptor-activating & cholinesterase-inhibiting drugs -- Chapter 8. Cholinoceptor-blocking drugs -- Chapter 9. Adrenoceptor agonists & sympathomimetic drugs -- Chapter 10. Adrenoceptor antagonist drugs -- Section III. Cardiovascular-renal drugs -- Chapter 11. Antihypertensive agents -- Chapter 12. Vasodilators & the treatment of angina pectoris -- Chapter 13. Drugs used in heart failure -- Chapter 14. Agents used in cardiac arrhythmias -- Chapter 15. Diuretic agents -- Section IV. Drugs with important actions on smooth muscle -- Chapter 16. Histamine, serotonin, & the ergot alkaloids -- Chapter 17. Vasoactive peptides -- Chapter 18. The eicosanoids: prostaglandins, thromboxanes, leukotrienes, & related compounds -- Chapter 19. Nitric oxide -- Chapter 20. Drugs used in asthma -- Section V. Drugs that act in the central nervous system -- Chapter 21. Introduction to the pharmacology of cns drugs -- Chapter 22. Sedative-hypnotic drugs -- Chapter 23. The alcohols -- Chapter 24. Antiseizure drugs -- Chapter 25. General anesthetics -- Chapter 26. Local anesthetics -- Chapter 27. Skeletal muscle relaxants -- Chapter 28. Pharmacologic management of parkinsonism & other movement disorders -- Chapter 29. Antipsychotic agents & lithium -- Chapter 30. Antidepressant agents -- Chapter 31. Opioid analgesics & antagonists -- Chapter 32. Drugs of abuse -- Section VI. Drugs used to treat diseases of the blood, inflammation, & gout -- Chapter 33. Agents used in anemias; hematopoietic growth factors -- Chapter 34. Drugs used in disorders of coagulation -- Chapter 35. Agents used in dyslipidemia -- Chapter 36. Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, & drugs used in gout -- Section VII. Endocrine drugs -- Chapter 37. Hypothalamic & pituitary hormones -- Chapter 38. Thyroid & antithyroid drugs -- Chapter 39. Adrenocorticosteroids & adrenocortical antagonists -- Chapter 40. The gonadal hormones & inhibitors -- Chapter 41. Pancreatic hormones & antidiabetic drugs -- Chapter 42. Agents that affect bone mineral homeostasis -- Section VIII. Chemotherapeutic drugs -- Overview. Chemotherapeutic drugs -- Chapter 43. Beta-lactam & other cell wall- & membrane-active antibiotics -- Chapter 44. Tetracyclines, macrolides, clindamycin, chloramphenicol, streptogramins, & oxazolidinones -- Chapter 45. Aminoglycosides & spectinomycin -- Chapter 46. Sulfonamides, trimethoprim, & quinolones -- Chapter 47. Antimycobacterial drugs -- Chapter 48. Antifungal agents -- Chapter 49. Antiviral agents -- Chapter 50. Miscellaneous antimicrobial agents; disinfectants, antiseptics, & sterilants -- Chapter 51. Clinical use of antimicrobial agents -- Chapter 52. Antiprotozoal drugs -- Chapter 53. Clinical pharmacology of the antihelminthic drugs -- Chapter 54. Cancer chemotherapy -- Chapter 55. Immunopharmacology -- Section IX. Toxicology -- Chapter 56. Introduction to toxicology: occupational & environmental -- Chapter 57. Heavy metal intoxication & chelators -- Chapter 58. Management of the poisoned patient -- Section X. Special topics -- Chapter 59. Special aspects of perinatal & pediatric pharmacology -- Chapter 60. Special aspects of geriatric pharmacology -- Chapter 61. Dermatologic pharmacology -- Chapter 62. Drugs used in the treatment of gastrointestinal diseases -- Chapter 63. Therapeutic & toxic potential of over-the-counter agents -- Chapter 64. Dietary supplements & herbal medications* -- Chapter 65. Rational prescribing & prescription writing -- Chapter 66. Important drug interactions & their mechanisms -- Vaccines, immune globulins, & other complex biologic products -- Schedule of controlled drugs. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Clinical pharmacology. |
| Source of heading or term |
BUEsh |
| 9 (RLIN) |
38454 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology. |
| Source of heading or term |
BUEsh |
| 9 (RLIN) |
12590 |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Source of heading or term |
BUEsh |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Resource For college |
Pharmacy |
| Arrived date list |
September2015 |
| 655 ## - INDEX TERM--GENRE/FORM |
|---|
| Form subdivision |
Reading book |
| -- |
34232 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Katzung, Bertram G., |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Masters, Susan B., |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Trevor, Anthony J., |
| Relator term |
editor. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Call number prefix |
615.1 BAS |